Media Centre | Press Releases

Geneva, 15 June 2016. The MCI Group has released in April 2016 a new thought leadership paper that focuses on the impact and effects of increasing transparency on the medical industry’s support of healthcare professionals and healthcare organisations.

MCI group releases new healthcare research paper

Geneva, 15 June 2016. The MCI Group has released in April 2016 a new thought leadership paper that focuses on the impact and effects of increasing transparency on the medical industry’s support of healthcare professionals and healthcare organisations.

The new paper aims to illustrate the key areas and influences associated with transparency, highlighting a range of viewpoints from key opinion leaders and commentators from medical associations and companies, trade associations, the press and observers.

The report, co-authored by Simon Dufaur, Strategy Consultant for Healthcare at MCI Brussels, and Cerstin Steindorf, Global Account Director for Healthcare at MCI Geneva, is based on field research carried out from December 2014 to February 2016 (OR over a period of 15 months).

It seeks to provide an insight on a number of healthcare industry topics such as whether healthcare compliance regulations and disclosure requirements have a positive impact on how the industry is perceived by the general public, and whether ethical codes concerning industry interactions with healthcare professionals have a direct benefit on their efficacy and patient care.

The report also highlights the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code – an initiative to harmonise transparency and disclosure requirements across 33 countries in Europe – and the Open Payments System in the United States. The concluding analysis focuses on the effects of transparency, risk management, predictions and recommendations.

MCI’s latest white paper illustrates its commitment to help healthcare companies and associations better engage their targeted audiences by rethinking traditional approaches, driving innovation and creating new experiences to foster change, inspire and educate.

MCI has been delivering successful medical meetings and congresses since 1987. Today, over half of its clients work in the healthcare and life sciences industry. The company manages over 2.800 healthcare events and more than 485.000 attendees annually from offices in over 30 countries globally.

The Healthcare Paper can be found here

ENDS

For more information please contact:

Sylvia Andre

MCI Group Marketing & Communications Director

sylvia.andre@mci-group.com

+41 (0) 22 33 99 500


ABOUT MCI

MCI is a global leader in engaging and activating audiences. Since 1987 we have been driving innovation in events and production, meetings, incentives, congresses, and association and community management. Through our creative consulting, analytics, sustainability and digital services, MCI helps multinational companies and international associations enhance their organisational performance, grow globally, energise communities and drive their business results. MCI is an independently owned company with headquarters in Geneva, Switzerland. Our 1,800 professionals in 60 cities and 31 countries help clients across Europe, the Americas, Asia-Pacific, India, the Middle East and Africa. Find out more at www.mci-group.com.



Download the PDF
Contact Us